Australia markets open in 5 hours 8 minutes

Australian Clinical Labs Limited (ACL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
4.2500+0.0300 (+0.71%)
At close: 4:10PM AEDT
Currency in AUD

Valuation measures

Market cap (intra-day) 5849.72M
Enterprise value 31.11B
Trailing P/E 10.61
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1.00
Price/book (mrq)10.38
Enterprise value/revenue 31.73
Enterprise value/EBITDA 75.97

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 324.27%
S&P500 52-week change 326.87%
52-week high 35.0800
52-week low 33.1800
50-day moving average 34.3692
200-day moving average 34.0549

Share statistics

Avg vol (3-month) 3634.72k
Avg vol (10-day) 3374.56k
Shares outstanding 5201.83M
Implied shares outstanding 6N/A
Float 8101.93M
% held by insiders 110.19%
% held by institutions 146.16%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.14
Trailing annual dividend yield 33.36%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2021
Most-recent quarter (mrq)30 June 2021

Profitability

Profit margin 9.34%
Operating margin (ttm)19.79%

Management effectiveness

Return on assets (ttm)19.03%
Return on equity (ttm)80.04%

Income statement

Revenue (ttm)646.7M
Revenue per share (ttm)4.25
Quarterly revenue growth (yoy)36.40%
Gross profit (ttm)520.23M
EBITDA 138.19M
Net income avi to common (ttm)60.37M
Diluted EPS (ttm)0.3970
Quarterly earnings growth (yoy)-58.70%

Balance sheet

Total cash (mrq)36.28M
Total cash per share (mrq)0.18
Total debt (mrq)294.26M
Total debt/equity (mrq)359.23
Current ratio (mrq)0.70
Book value per share (mrq)0.41

Cash flow statement

Operating cash flow (ttm)153.86M
Levered free cash flow (ttm)171.07M